Patents by Inventor Charles H. Kirkpatrick

Charles H. Kirkpatrick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Characterization of transfer factors and methods of use
    Patent number: 5883224
    Abstract: Characterization of transfer factors is provided in the form of amino acid and nucleic acid sequences corresponding to at least a portion of a conserved transfer factor region. The amino acid and nucleic acid sequences, or functional homologues thereof, are provided along with methods of use thereof for diagnostic, therapeutic and other purposes.
    Type: Grant
    Filed: April 19, 1996
    Date of Patent: March 16, 1999
    Assignee: Cytokine Sciences, Inc.
    Inventors: Charles H. Kirkpatrick, Martin J. McDermott, Stephen P. Eisenberg
  • Methods of producing transfer factor
    Patent number: 5840700
    Abstract: The invention relates to substantially pure transfer factor with a specific activity of at least 5000 units per absorbance unit at 214 nm. The present invention also relates to a process for preparing the transfer factor from cell lysates. The present invention includes the use of substantially pure transfer factor with a specific activity of at least 5000 units per absorbance unit at 214 nm to treat infectious diseases.
    Type: Grant
    Filed: May 16, 1995
    Date of Patent: November 24, 1998
    Assignee: National Jewish Center for Immunology and Respiratory Medicine
    Inventors: Charles H. Kirkpatrick, Stephen J. Rozzo
  • Transfer factor and methods of use
    Patent number: 5470835
    Abstract: The invention relates to substantially pure transfer factor with a specific activity of at least 5000 units per absorbance unit at 214 nm. The present invention also relates to a process for preparing the transfer factor from cell lysates. The present invention includes the use of substantially pure transfer factor with a specific activity of at least 5000 units per absorbance unit at 214 nm to treat infectious diseases.
    Type: Grant
    Filed: July 22, 1994
    Date of Patent: November 28, 1995
    Assignee: National Jewish Center for Immunology and Respiratory Medicine
    Inventors: Charles H. Kirkpatrick, Stephen J. Rozzo